By addressing these metabolic disturbances, the combination therapy may indirectly protect neuronal integrity and cognitive function
I spoke with endocrinologist Francis Finucane, who told me how we see these large differences in response to drugs like Wegovy (semaglutide) and Mounjaro (tirzepatide), where some people lose 40% of their body weight, and 1 in 10 don't lose any weight at all
We are seeing a transition from biochemical discovery to delivery engineering
Both work through the same mechanismactivating GLP-1 receptors to reduce appetite and slow gastric emptyingbut compounded options remove the manufacturing markup, making the therapy more financially accessible for people managing weight loss
Choe KY, Han SY, Gaub P, et al
Patients can administer the injection themselves after receiving appropriate guidance from a healthcare provider